The adverse reactions associated with the use of Empagliflozin include: Hypotension; Ketoacidosis; Acute Kidney Injury and Impairment in Renal Function; Urosepsis and Pyelonephritis; Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues; Genital Mycotic Infections; Increased Low-Density Lipoprotein Cholesterol (LDL-C).